| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G9012 |
Other specified case management service not elsewhere classified |
3,055 |
1,455 |
$338K |
| G9008 |
Coordinated care fee, physician coordinated care oversight services |
902 |
683 |
$90K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
882 |
735 |
$9.38 |
| 80053 |
Comprehensive metabolic panel |
1,180 |
983 |
$3.71 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
834 |
613 |
$0.00 |
| 86703 |
|
204 |
204 |
$0.00 |
| 80061 |
Lipid panel |
584 |
581 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
41 |
41 |
$0.00 |
| 3078F |
|
323 |
296 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
12 |
12 |
$0.00 |
| 86480 |
|
43 |
43 |
$0.00 |
| 86705 |
|
12 |
12 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
21 |
21 |
$0.00 |
| 82274 |
|
30 |
30 |
$0.00 |
| 82540 |
|
12 |
12 |
$0.00 |
| 90750 |
|
14 |
14 |
$0.00 |
| 3077F |
|
35 |
34 |
$0.00 |
| 86765 |
|
15 |
15 |
$0.00 |
| 3074F |
|
271 |
247 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
2,230 |
1,806 |
$0.00 |
| 87340 |
|
99 |
99 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
76 |
66 |
$0.00 |
| 82043 |
|
12 |
12 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
744 |
737 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
212 |
208 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
41 |
41 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
177 |
161 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
118 |
113 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
177 |
176 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
110 |
110 |
$0.00 |
| 3044F |
|
153 |
152 |
$0.00 |
| 90686 |
|
23 |
23 |
$0.00 |
| 86762 |
|
26 |
26 |
$0.00 |
| 86706 |
|
36 |
36 |
$0.00 |
| 1111F |
|
48 |
44 |
$0.00 |
| 85027 |
|
28 |
26 |
$0.00 |
| 1220F |
|
14 |
13 |
$0.00 |
| 86780 |
|
71 |
71 |
$0.00 |
| 86738 |
|
15 |
15 |
$0.00 |
| 81001 |
|
28 |
28 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
12 |
12 |
$0.00 |
| 3079F |
|
14 |
13 |
$0.00 |
| 3075F |
|
38 |
37 |
$0.00 |